Hints and tips:
Related Special Reports
...AbbVie and Eli Lilly have withdrawn from the deal after the German conglomerate Bayer’s pharmaceutical chief executive told the Financial Times on Monday that it was reducing its UK footprint and cutting...
...“[Investors] have been fairly traumatised by the Bayer Monsanto situation and the Johnson & Johnson talc litigation,” said Bernstein analyst Lisa Clive, referring to two recent multibillion-dollar payouts...
...After such strong reads from the first two releases (three if we count Russia’s Sputnik V), the disappointing AZN figures were perhaps bound to prompt downward pressure on the company’s shares....
...The prospect of much lower bond yields — and, crucially, the expectation that central banks will contain any sharp rise — has encouraged investors to boost their exposure to the technology and healthcare...
...Bayer, the German pharmaceutical group, also said it would donate 3m of its malaria tablets, but as they are not approved in the US, they need an emergency authorisation from the FDA....
..., net of income taxes, (ii) net income (loss) attributable to non-controlling interests, net of tax, (iii) provision for (benefit from) income taxes, (iv) income (loss) from equity method investments, (v)...
...Bayer, for instance, has struggled since digesting its Monsanto purchase, with its market value falling by more than $45bn since the deal.....
...His hedge fund Elliott Management has disclosed a stake in the software company SAP, the troubled healthcare and agriculture conglomerate Bayer and the online classifieds group Scout24, this year alone....
...software company valued at $2.5bn, says he has spent a lot of time trying to figure out why Germany has lost the spirit of the Gründerzeit — the “founding epoch” in the late 19th century when Daimler, Bayer...
...AstraZeneca Plc has made a preliminary approach to rival drugmaker Gilead Sciences Inc. about a potential merger, according to people familiar with the matter, in what would be the biggest health-care deal...
...It was this statement of corporate social responsibility — crafted decades before the term became overused PR — which he said had guided the world’s largest healthcare company to become a solid, long-term...
...The 62-year old, who’s a supervisory board member at Bayer, witnessed the unprecedented vote of no confidence that investors delivered to the company last month....
...Ms Schoen said she believed it was unlikely that the court would overturn Roe v Wade....
...Robert Bayer and Ajay Singh have joined Macquarie Capital as senior managing directors in the industrials group. Bayer joins from Guggenheim Securities and Singh from UBS....
...Two years later, the share price of Covestro, the plastics unit of German chemicals company Bayer, doubled within its first year as an independent company, trouncing Bayer’s performance....
...That puts it ahead of its nearest competitors Johnson & Johnson, Sanofi and Bayer, which hold about 4 per cent market shares each....
...Qubits v bytes: how quantum computing works Quantum computing taps into the quirky behaviour of sub-atomic particles, which bend our normal understanding of physics....
...Reckitt cited financial discipline for quitting the two-horse race, as it also did in 2014, when it withdrew from bidding for the healthcare unit of Merck of the US, leaving Germany’s Bayer to clinch the...
...In 2014, Bayer paid seven times sales to German peer Merck in a $14bn deal....
...Nestlé, the Swiss foods group, has said that it is in the market for such assets, while analysts also cite drugmakers such as GlaxoSmithKline, Bayer, Sanofi and Johnson & Johnson as potential buyers....
...This fourth tranche of 30 ideas (listed below) is about the latest advances in healthcare. The fifth and final chapter, looking at Earth and the universe, will be published on March 29, 2018....
...Smart reads David v Goliath Large consumer goods companies are starting to feel the impact of their smaller, more innovative rivals....
...By acquiring Bayer’s diabetes care business in early 2016 and combining it with the Panasonic division, the new owner was able to double revenues....
...But Alexander Moscho, UK head of Bayer, the German drugmaker, says the qualy system is not flexible enough for the new world of personalised medicines....
...Banker v. Former Employer, NYC edition Jason Schoenholtz, a senior healthcare banker, must really have wanted to work at somewhere other than RBC Capital Markets....
International Edition